Antibody cocktail

The price for each patient dose [a combined dose of 1,200 mg (600 mg of Casirivimab and 600 mg of Imdevimab)] will be Rs 59,750 inclusive of all taxes. The maximum retail price for the multi dose pack (each pack can treat two patients) is Rs 1,19,500 inclusive of all taxes.

In a first for the Tricity, monoclonal antibody cocktail therapy against Covid was administered to a patient, a 72-year-old with diabetes and chronic kidney disease, at a private hospital in Mohali.

Fifty Covid-19 patients who received single-dose monoclonal antibodies cocktail drug (casirivimab and imdevimab) were relieved of their symptoms within 24 hours of the therapy given at the AIG Hospitals in Hyderabad.

Apollo Hospital in the city claimed to have become the first to administer Roche’s antibody cocktail to a patient with a high risk from Covid-19. The antibody cocktail was administered to a 65-year-old man who responded well and was discharged after an hour of observation. It was administered to patients with mild and moderate Covid and at high risk of developing severe Covid, officials said.

An 84-year-old man from Haryana has become the first person in India to be administered the Covid drug cocktail, which came into limelight after it was administered to former US President Donald Trump when he tested positive for the virus last year.

An 82- year-old Covid-19 patient undergoing treatment in Apollo Hospital in Odisha's capital city Bhubaneswar is the first patient in the state to get an antibody cocktail- a combination of two injections for treatment of the deadly disease.

antibody cocktail shots — an combination injection that was pushed into the limelight after former US president Donald Trump was administered one last year — has become the latest addition in treatment of Covid-19 positive patients in Gujarat.

At least four patients infected with Covid-19 in Kolkata have been administered the much talked about antibody cocktail — a combination of Casirivimab and Imdevimab. This therapy, meant specially for mild to moderately infected patients, has brought hope for patients with co-morbid conditions.

BLK-Max Hospital on Tuesday claimed two patients who were given monoclonal antibody cocktail recently have recovered from Covid within eight days, which is a record.

For the first time in Andhra Pradesh, doctors administered a monoclonal antibody cocktail injection to a Covid-19 patient at Ayush Hospital in the city on Friday

The Insurance Regulatory and Development Authority of India (Irdai) has asked companies not to reject Covid claims for antibody cocktail therapy by terming it as an ‘experimental’ treatment. The regulator has also asked insurers to review the claims denied or deductions made in all such situations and take appropriate action to settle them according to the terms of the policy.

Nearly three patients in Kerala have been given the latest Covid treatment, the antibody cocktail that was also given to former US President Donald Trump. Of the three who were given the intravenous medicine, two are transplant patients too.

The Insurance Regulatory and Development Authority of India (Irdai) has asked companies not to reject Covid claims for antibody cocktail therapy by terming it as an ‘experimental’ treatment.

The health department on Tuesday scrapped monoclonal antibody cocktail and antiviral molnupiravir in its revised Covid treatment protocol. The antibody cocktail therapy and the antiviral had found place in treatment guideline which was issued on Saturday. Sources in the health department said scrapping these two drugs/therapy will prevent the misuse.

Roche's antibody-drug has been reserved for emergency use in patients who have mild to moderate symptoms and have chances of getting a severe infection.

The Haryana government on Wednesday started distributing vials of monoclonal antibodies that have received emergency use authorisation to treat Covid patients to hospitals in the state.

India's Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild Covid-19. The treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials, the drugmaker said, adding it was found to be safe and well-tolerated.

Insurers and third-party administrators (TPA) in Kolkata are witnessing a flood of queries and claims for Covid antibody cocktail therapy following insurance regulator IRDA’s nod to the treatment earlier this month.

For most individuals with COVID, symptom-based treatment is all that is needed. Paracetamol for fever, decongestants and antihistamines for nasal congestion and inhaled corticosteroids for cough. There are drugs used for COVID treatment but there are limitations to each and we all should act responsibly and not in panic.